Health and Fitness Health and Fitness
Fri, August 6, 2010
[ Fri, Aug 06th 2010 ] - Market Wire
Exelixis Announces August 12 Webcast of Presentat .. e Canaccord Genuity 30th Annual Growth Conference
[ Fri, Aug 06th 2010 ] - Market Wire
Micromet Reports Second Quarter 2010 Financial Results
[ Fri, Aug 06th 2010 ] - Market Wire
Inspire Announces Webcast of Presentation at Bank .. errill Lynch Specialty Pharmaceuticals Conference
Thu, August 5, 2010
[ Thu, Aug 05th 2010 ] - Market Wire
IMRIS reports second quarter 2010 results
[ Thu, Aug 05th 2010 ] - Market Wire
Hanger Orthopedic, AMB Property, MasterCard, Visa and Pfizer
[ Thu, Aug 05th 2010 ] - Market Wire
CombinatoRx Reports Financial Results for the Second Quarter 2010
[ Thu, Aug 05th 2010 ] - Market Wire
Transcend Awarded Child Health Corporation of America (CHCA) Contract
[ Thu, Aug 05th 2010 ] - Market Wire
Finkelstein Thompson LLP Announces Investigation of Almost Family, Inc.
[ Thu, Aug 05th 2010 ] - Market Wire
CML HealthCare Income Fund Announces Release Date for Fiscal 2010 Second Quarter Financial Results
[ Thu, Aug 05th 2010 ] - Market Wire
Molina Healthcare Announces Common Stock Offering
[ Thu, Aug 05th 2010 ] - Market Wire
Affymax® Reports Second Quarter 2010 Financial Results
[ Thu, Aug 05th 2010 ] - Market Wire
PharmMD and Prescription Solutions Go Live
[ Thu, Aug 05th 2010 ] - Market Wire
SDIX Reports Second Quarter 2010 Results
[ Thu, Aug 05th 2010 ] - Market Wire
ImmunoGen, Inc. Reports Fourth Quarter and Fiscal Year 2010 Financial Results
[ Thu, Aug 05th 2010 ] - Market Wire
Alnylam Pharmaceuticals Reports Second Quarter 2010 Financial Results
[ Thu, Aug 05th 2010 ] - Market Wire
Targacept Reports Second Quarter 2010 Financial Results
[ Thu, Aug 05th 2010 ] - Market Wire
Bioject Reports Second Quarter 2010 Financial Results
[ Thu, Aug 05th 2010 ] - Market Wire
MannKind to Present at the 30th Annual Canaccord Genuity Growth Conference
[ Thu, Aug 05th 2010 ] - Market Wire
Ramius Highlights Concerns Regarding Recent Trans .. otion With Forest Laboratories Without First Expl
[ Thu, Aug 05th 2010 ] - Market Wire
Media Advisory - Oncolytics Biotech(R) Inc. to Pr .. t 30th Annual Canaccord Genuity Growth Conference
[ Thu, Aug 05th 2010 ] - Market Wire
Aeterna Zentaris Announces NIH Grant for a Phase .. 2 Study in Advanced Prostate Cancer with AEZS-108
[ Thu, Aug 05th 2010 ] - Market Wire
YM BioSciences announces conclusion of Phase I do .. nsion of ongoing CYT387 Phase I/II clinical study
[ Thu, Aug 05th 2010 ] - Market Wire
Quidel to Present at Canaccord Genuity 30th Annual Growth Conference
[ Thu, Aug 05th 2010 ] - Market Wire
FDA Approves New Taxotere® (docetaxel) Injection Concentrate Formulation
Wed, August 4, 2010
[ Wed, Aug 04th 2010 ] - Market Wire
Somaxon Pharmaceuticals to Report Second Quarter .. d Conduct Conference Call on Wednesday, August 11
[ Wed, Aug 04th 2010 ] - Market Wire
ZIOPHARM Oncology to Present at the Canaccord Genuity 30th Annual Global Growth Conference
[ Wed, Aug 04th 2010 ] - Market Wire
Orthofix International to Participate in Canaccord Genuity Growth Conference
[ Wed, Aug 04th 2010 ] - Market Wire
Abiomed Reports Record U.S. Impella Utilization for First Quarter of Fiscal 2011
[ Wed, Aug 04th 2010 ] - Market Wire
Celldex Reports Second Quarter 2010 Financial Results
[ Wed, Aug 04th 2010 ] - Market Wire
Aeterna Zentaris to Announce Second Quarter 2010 .. inancial and Operating Results on August 12, 2010

Aeterna Zentaris to Announce Second Quarter 2010 Financial and Operating Results on August 12, 2010


Published on 2010-08-04 07:46:29 - Market Wire
  Print publication without navigation


QUÉBEC CITY, Aug. 4 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company"), a late-stage drug development company specialized in oncology and endocrinology, will announce its second quarter 2010 financial and operating results before market open on Thursday, August 12, 2010. The Company will host a conference call and webcast to discuss these results later that same day at 1:30 p.m., Eastern Time.

Participants may access the live webcast via the Company's website at [ www.aezsinc.com ] in the "Investors" section, or by telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7451, outside Canada, 888-231-8191. A replay of the webcast will also be available on the Company's website for a period of 30 days.

About Aeterna Zentaris Inc.

Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrinology. News releases and additional information are available at [ www.aezsinc.com ].

Contributing Sources